Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Pulmonary complications of tissue transplantation in children
1Division of Pediatric Pulmonary Medicine, Vanderbilt University Medical School, Nashville, TN 37232.
Insights
Pediatric transplant survival has improved, but lung complications like infections and interstitial pneumonias remain significant challenges. Early detection and new therapies offer hope for better outcomes in bone marrow and organ transplant recipients.
Area of Science:
- Pediatric Hematology/Oncology
- Transplant Medicine
- Pulmonology
Background:
- Pediatric bone marrow and solid organ transplantation expanded significantly in the 1980s.
- Advances in antibiotics, preparative regimens, and graft-versus-host disease management improved overall transplant survival.
- Pulmonary complications continue to be a major cause of morbidity and mortality in pediatric transplant patients.
Purpose of the Study:
- To review the major pulmonary complications in pediatric transplant patients.
- To discuss current and emerging diagnostic and therapeutic strategies for these complications.
- To highlight the challenges in managing opportunistic infections and noninfectious lung diseases post-transplantation.
Main Methods:
- Literature review of pulmonary complications in pediatric bone marrow and solid organ transplantation.
- Analysis of trends in infectious and noninfectious pulmonary problems.
- Evaluation of recent advancements in diagnosis and treatment of cytomegalovirus and fungal pneumonias.
Main Results:
- Fungal and cytomegalovirus infections are the leading infectious pulmonary complications.
- Idiopathic interstitial pneumonias and bronchiolitis obliterans are the primary noninfectious pulmonary issues.
- New antiviral therapies and polymerase chain reaction (PCR) detection methods show promise for cytomegalovirus pneumonia management.
Conclusions:
- Pulmonary complications remain a critical challenge in pediatric transplantation despite overall survival improvements.
- Early diagnosis and effective treatment of fungal and cytomegalovirus infections are essential.
- Continued research into novel diagnostic tools and therapeutic interventions is crucial for improving outcomes.
Abstract:
Pediatric bone marrow transplantation and transplantation of solid organs rapidly expanded during the 1980s. Antibiotic therapy for bacterial pneumonias, improved transplant preparative regimens, and improvements in prevention and therapy of graft-versus-host disease have made possible significant improvements in overall bone marrow transplant survival. Despite these advances, pulmonary complications of transplantation remain major causes of morbidity and mortality in pediatric transplant patients. Fungal and cytomegalovirus infections have emerged as the major posttransplant pulmonary infections whereas idiopathic interstitial pneumonias and bronchiolitis obliterans are the major noninfectious pulmonary problems. Recent developments in antiviral therapy for cytomegalovirus pneumonia offer hope that the dismal prognosis of cytomegalovirus pneumonia in transplant patients can be improved. New early detection methods for cytomegalovirus using polymerase chain reaction may also help identify patients for prophylactic therapy and prevent development of cytomegalovirus pneumonitis. Early diagnosis and treatment for fungal pneumonias and other opportunistic pathogens remain significant challenges in immunocompromised transplant patients.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pulmonary Cycle: Exhalation

